Osteoclast-specific genes and proteins and uses thereof

Details Osteoclast-specific genes and proteins and uses thereof Osteoclast-specific genes and proteins and uses thereof

2007-01-09

2007-01-09

Wax, Robert A. (Department: 1653)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C435S069100, C435S325000

Reexamination Certificate

active

10368087

ABSTRACT:
Isolated nucleic acid and amino acid sequence for osteoclast-specific genes and proteins are provided. Methods for using these osteoclast-specific genes and proteins in the detection and isolation of osteoclasts, in production of antibodies specific to osteoclasts and to identify agents capable of modulating osteoclast function and treating diseases linked to osteoclasts are also provided.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 6403304 (2002-06-01), Stashenko et al.
patent: 2003/0064379 (2003-04-01), Baker et al.
patent: 2004/0157771 (2004-08-01), Bird et al.
patent: 1 087 230 (1999-09-01), None
patent: WO 88/00205 (1988-01-01), None
patent: WO 00/13024 (2000-03-01), None
Ausubel et al., 1989 Current Protocols in Molecular Biology, vol. I, Green Publishing Associates, Inc. And John Wiley & Sons, Inc. N.Y.
Centrella et al., “Transforming Growth Factor : Is a Bifunctional Regulator of Replication and Collagen Synthesis in Osteoblast-enriched Cell Cultures from Fetal Rat Bone”, J. Biol. Chem. 1987 262(6):2869-2874.
Hsu et al., “Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand”, Proc. Natl. Acad. Sci. USA 1999 96:3540-3545.
Hunt et al., “Cellular mechanisms of bone resorption in breast carcinoma”, British Journal of Cancer 2001 85(1):78-84.
Isgaard et al., “Effects of local administration of GH and IGF-1 on longitudinal bone growth in rats”, Am. J. Physicl. 250 (Endocrinol. Metab. 13):E367-E372 1986.
Joyce et al., “Transforming Growth Factor-β and the Initiatior. of Chondrogenesis and Osteogenesis in the Rat Femur”, J. Cell Biology 1990 110:2195-2207.
Kiebzak et al., “Bone Status of Senescent Female Fats:Chemical, Morphometric, and Biomechanical Analyses”, J. Bone and Mineral Research 1988 3(4):439-446.
Kim et al., “A Novel Member of the Leukocyte Feceptor Complex Regulates Osteoclast Differentiation”, J. Exp. Med. 2002 195:201-209.
Sambrook et al., Molecular Cloning 1989 Cold Spring Harbor Laboratory Press.
Slovik et al., “Restoration of Spinal Bone in Osteoporotic Men by Treatment with Human Parathyroid Hormone (1-34) and 1, 25-Dihydroxyvitamin D”, J. Bone & Min. Res. 1986 1:377-381.
Chenu et al., “Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures”, Proc. Natl. Acad. Sci. USA 1988 85:5683-5687.
Kohler and Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity”, Nature 1975 256:495-497.
Kozbor and Roder, “The production of monoclonal antibodies from human lymphocytes”, Immunology Today 1983 4(3):72-79.
Noda and Camilliere, “In Vivo Stimulation of Bone Formation by Transforming Growth Factor-β”, Endocrinology 1989 124:2991-2294.

Affiliated with

Also associated with

Rating

Osteoclast-specific genes and proteins and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Osteoclast-specific genes and proteins and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Osteoclast-specific genes and proteins and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3755480